Kenneth M Cohen - Net Worth and Insider Trading
Kenneth M Cohen Net Worth
The estimated net worth of Kenneth M Cohen is at least $656,767 dollars as of 2024-04-18. Kenneth M Cohen is the Member of 10% owner group of Core Lithium Corp and owns about 656,755 shares of Core Lithium Corp (CORX) stock worth over $656,755. Kenneth M Cohen is the Director of MabVax Therapeutics Holdings Inc and owns about 450 shares of MabVax Therapeutics Holdings Inc (MBVXQ) stock worth over $10. Kenneth M Cohen is also the Director of DMK Pharmaceuticals Corp and owns about 42 shares of DMK Pharmaceuticals Corp (DMKPQ) stock worth over $2. Details can be seen in Kenneth M Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth M Cohen has not made any transactions after 2015-05-22 and currently still holds the listed stock(s).
Transaction Summary of Kenneth M Cohen
Kenneth M Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth M Cohen owns 3 companies in total, including MabVax Therapeutics Holdings Inc (MBVXQ) , DMK Pharmaceuticals Corp (DMKPQ) , and RespireRx Pharmaceuticals Inc (RSPI) .
Click here to see the complete history of Kenneth M Cohen’s form 4 insider trades.
Insider Ownership Summary of Kenneth M Cohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MBVXQ | MabVax Therapeutics Holdings Inc | 2018-04-02 | director |
| DMKPQ | DMK Pharmaceuticals Corp | 2011-01-12 | director |
| RSPI | RespireRx Pharmaceuticals Inc | 2013-03-22 | other: Member of 10% owner group |
Kenneth M Cohen Latest Holdings Summary
Kenneth M Cohen currently owns a total of 3 stocks. Among these stocks, Kenneth M Cohen owns 656,755 shares of Core Lithium Corp (CORX) as of March 22, 2013, with a value of $656,755 and a weighting of 100%. Kenneth M Cohen owns 450 shares of MabVax Therapeutics Holdings Inc (MBVXQ) as of May 22, 2015, with a value of $10 and a weighting of 0%. Kenneth M Cohen also owns 42 shares of DMK Pharmaceuticals Corp (DMKPQ) as of January 12, 2011, with a value of $2 and a weighting of 0%.
Latest Holdings of Kenneth M Cohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORX | Core Lithium Corp | 2013-03-22 | 656,755 | 1.00 | 656,755 |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2015-05-22 | 450 | 0.02 | 10 |
| DMKPQ | DMK Pharmaceuticals Corp | 2011-01-12 | 42 | 0.05 | 2 |
Holding Weightings of Kenneth M Cohen
Kenneth M Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth M Cohen has made a total of 0 transactions in Core Lithium Corp (CORX) over the past 5 years. The most-recent trade in Core Lithium Corp is the sale of 0 shares on March 22, 2013, which brought Kenneth M Cohen around $0.
According to the SEC Form 4 filings, Kenneth M Cohen has made a total of 0 transactions in MabVax Therapeutics Holdings Inc (MBVXQ) over the past 5 years. The most-recent trade in MabVax Therapeutics Holdings Inc is the acquisition of 158 shares on May 22, 2015, which cost Kenneth M Cohen around $8,050.
According to the SEC Form 4 filings, Kenneth M Cohen has made a total of 0 transactions in DMK Pharmaceuticals Corp (DMKPQ) over the past 5 years. The most-recent trade in DMK Pharmaceuticals Corp is the sale of 0 shares on January 12, 2011, which brought Kenneth M Cohen around $0.
Insider Trading History of Kenneth M Cohen
- 1
Kenneth M Cohen Trading Performance
GuruFocus tracks the stock performance after each of Kenneth M Cohen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth M Cohen is -36.68%. GuruFocus also compares Kenneth M Cohen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth M Cohen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth M Cohen's insider trading performs compared to the benchmark.
Performance of Kenneth M Cohen
Average Relative Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | -1.22 | -36.68 | -56.33 | -70.97 | -68.18 | -70.13 |
| Relative Return to S&P 500(%) | -1.07 | -29.38 | -54.59 | -67.5 | -74.29 | -78.74 |
Kenneth M Cohen Ownership Network
Ownership Network List of Kenneth M Cohen
Ownership Network Relation of Kenneth M Cohen
Kenneth M Cohen Owned Company Details
What does MabVax Therapeutics Holdings Inc do?
Who are the key executives at MabVax Therapeutics Holdings Inc?
Kenneth M Cohen is the director of MabVax Therapeutics Holdings Inc. Other key executives at MabVax Therapeutics Holdings Inc include CHIEF FINANCIAL OFFICER & SECR Gregory P Hanson , EXEC. VP & R AND D Paul W Maffuid , and 10 percent owner David S Wetherell .
MabVax Therapeutics Holdings Inc (MBVXQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of MabVax Therapeutics Holdings Inc (MBVXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MabVax Therapeutics Holdings Inc (MBVXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
MabVax Therapeutics Holdings Inc (MBVXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
MabVax Therapeutics Holdings Inc Insider Transactions
Kenneth M Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth M Cohen. You might contact Kenneth M Cohen via mailing address: 12750 High Bluff Drive, Suite 310, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
